e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Cough and sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Associated pathologies and tobacco habit in patients diagnosed of obstructive sleep apnoea syndrome treated with nCPAP
P. Cebollero, J. A. Cascante, J. Abú, J. Boldú, V. M. Egua, J. Hueto (Pamplona, Spain)
Source:
Annual Congress 2002 - Cough and sleep apnoea
Session:
Cough and sleep apnoea
Session type:
Thematic Poster Session
Number:
2860
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Cebollero, J. A. Cascante, J. Abú, J. Boldú, V. M. Egua, J. Hueto (Pamplona, Spain). Associated pathologies and tobacco habit in patients diagnosed of obstructive sleep apnoea syndrome treated with nCPAP. Eur Respir J 2002; 20: Suppl. 38, 2860
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
A 12-year-old male child with fever, productive cough and sudden onset paralysis
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Treatment control in risk patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 411s
Year: 2006
Compliance with CPAP/BiPAP treatment in obstructive sleep apnea syndrome patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Investigation of the prevalence of obstructive sleep apnea syndrome in patients with diagnosed subclinicalhypothyroidism
Source: Sleep and Breathing Conference 2021
Year: 2021
Compliance with nCPAP in elderly patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2004; 24: Suppl. 48, 569s
Year: 2004
Severe obstructive sleep apnea patients and smoking cessation
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009
Unrecognised hypertension in patients screened for obstructive sleep apnoea
Source: Eur Respir J 2005; 26: Suppl. 49, 40s
Year: 2005
The influence of obesity in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 295s
Year: 2002
Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients.
Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea
Year: 2019
Should patients with obstructive sleep apnea syndrome be screened for hypothyroidism?
Source: Eur Respir J 2005; 26: Suppl. 49, 569s
Year: 2005
Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Perennial allergies in patients treated with nCPAP for obstructive sleep apnoea
Source: Eur Respir J 2001; 18: Suppl. 33, 216s
Year: 2001
Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009
Enuresis in obstructive sleep apnea syndrome patients
Source: Annual Congress 2012 - Sleep apnoea: clinical topics
Year: 2012
Comorbidities of obstructive sleep apnoea syndrome
Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Year: 2011
ME1 Treating obstructive sleep apnoea syndrome in children
Source: Milan 2017 - Educational material
Year: 2017
PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment
Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing
Year: 2012
Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 97s
Year: 2003
The symptom prevalence of obstructive sleep apnea syndrome in patients with asthma and COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 198s
Year: 2006
The prevalence of unrecognized obstructive sleep apnea syndrome among patients with nocturnal symptoms and poorly controlled asthma
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017
Prevalence of obstructive sleep apnea in patients with difficult-to-treat asthma
Source: Annual Congress 2011 - Asthma: risk factors and comorbidities
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept